Reata Pharma (RETA) Prices 5.5M Class A Common Stock IPO at $11/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Wall Street sinks as bond yields rise, Walmart results disappoint
Reata Pharmaceuticals (RETA) IPO Opens Flat
May 26, 2016 10:39 AM EDTToday's IPO for Reata Pharmaceuticals, Inc. (Nasdaq: RETA) opened for trading at $11.06 after pricing 5,500,000 shares of its Class A common stock at $11.00 per share. The company was recently looking to offer 4 million shares and expected a pricing range of $14 - $16 per... More
